Shopping Cart
- Remove All
Your shopping cart is currently empty
Neuromedin U-25 human, the active form of neuromedin U in humans, inhibits glucose-stimulated insulin secretion, leading to early-onset obesity, and serves as a vasoconstrictor in human vascular beds [1][2].

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 10 mg | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry |
| Description | Neuromedin U-25 human, the active form of neuromedin U in humans, inhibits glucose-stimulated insulin secretion, leading to early-onset obesity, and serves as a vasoconstrictor in human vascular beds [1][2]. |
| In vitro | Neuromedin U-25 human (4 pM-2 nM) binds to receptors in the human left ventricle and coronary artery, with K D values of 0.26 and 0.11 nM, respectively [1]. Additionally, Neuromedin U-25 human (0.1 nM-0.1 μM) induces endothelium-independent contraction in coronary, mammary, and saphenous vessels, with contraction potencies (pD 2) of 8.6, 8.0, and 8.2, respectively [1]. |
| Molecular Weight | 3080.37 |
| Formula | C141H203N41O38 |
| Cas No. | 312306-89-1 |
| Sequence | Phe-Arg-Val-Asp-Glu-Glu-Phe-Gln-Ser-Pro-Phe-Ala-Ser-Gln-Ser-Arg-Gly-Tyr-Phe-Leu-Phe-Arg-Pro-Arg-Asn-NH2 |
| Sequence Short | FRVDEEFQSPFASQSRGYFLFRPRN-NH2 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.